The exterior of the Food And Drug Administration headquarters is seen on July 20, 2020, in White Oak, Maryland. This story was originally published on BioPharma Dive. To receive daily news and ...
Soleno Therapeutics, Inc. announced its participation in the 2025 United In Hope: International Prader-Willi Syndrome Conference, scheduled for June 24-28, 2025, in Phoenix, AZ. The company will ...
Prader-Willi syndrome (PWS) is a rare genetic condition marked by uncontrolled hunger and complex behavioral and medical ...
Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, ...
SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, making it the first treatment available for patients who experience ...
Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 ...
Prader-Willi syndrome or PWS is a rare condition that can affect children from 0 to 6 years of age. It is a multisystem genetic disorder caused by the loss of paternally expressed genes on chromosome ...
New research from the University of East Anglia (UK) reveals the hidden struggles experienced by the brothers and sisters of people with Prader–Willi syndrome. Biomedical engineers at Duke University ...
Hosted on MSN
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved
Shares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company announced the launch of its VYKAT XR extended-release tablets in the U.S. as a ...
We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Genmab A/S is one of them. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results